Zur Rose Group AG
SIX:ROSE
Relative Value
The Relative Value of one ROSE stock under the Base Case scenario is 63.29 CHF. Compared to the current market price of 32.3 CHF, Zur Rose Group AG is Undervalued by 49%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
ROSE Competitors Multiples
Zur Rose Group AG Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
CH |
Z
|
Zur Rose Group AG
SIX:ROSE
|
374.9m CHF | 0.2 | -2.2 | -6.4 | -3.4 | |
ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
71.6B Zac | 0 | 0 | 0 | 0 | |
ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
28B Zac | 0 | 0 | 0 | 0 | |
US |
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
15B USD | 0.1 | -2.5 | 5.2 | 11.5 | ||
BR |
Raia Drogasil SA
BOVESPA:RADL3
|
43.9B BRL | 1.3 | 41.6 | 12.6 | 22.5 | ||
CN |
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
44.2B CNY | 2 | 30.7 | 21.5 | 21.5 | ||
JP |
MatsukiyoCocokara & Co
TSE:3088
|
941.9B JPY | 0.9 | 18.6 | 9.2 | 11.9 | ||
SA |
Al Nahdi Medical Company SCJSC
SAU:4164
|
17.9B SAR | 2 | 20 | 11.3 | 18.6 | ||
MX |
Corporativo Fragua SAB de CV
BMV:FRAGUAB
|
74.3B MXN | 0.7 | 16.5 | 7.5 | 8.8 | ||
JP |
Cosmos Pharmaceutical Corp
TSE:3349
|
577.2B JPY | 0.6 | 24 | 11.3 | 18.2 | ||
CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
24.7B CNY | 1 | 19.2 | 14.7 | 14.7 |